← Leaderboards
Preeti Viswanathan
Albert Einstein College Of Medicine
$837,420
Attributed
$837,420
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $168.7K · FY2021–25$200K$150K$100K$50K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$837,420 · 1
By mechanism
K08$837,420 · 1
Top collaborators
No co-investigators on record.
Most similar at Albert Einstein College Of Medicine
Same institution · by research overlap
- Michael Oertel$3,446,192
Others in their field
Other Emerging Leaders on “Acetaminophen”
- Cecile Feldman · Rbhs-School Of Dental Medicine$11,278,781
- Prashant Mishra · Ut Southwestern Medical Center$2,999,512
- Lisa Doan · New York University School Of Medicine$2,885,464
- Andrew Wang · Yale University$2,853,345
- Daniel J. Wallace · Upstate Medical University$2,360,490
- Chani Traube · Children'S Research Institute$2,288,784
Research focus
AcetaminophenCell ProliferationAdductAdolescenceAdultAcute Liver FailureAtaxia Telangiectasia Mutated ProteinAtm ActivationAtm GeneAtm Signaling PathwayAutomobile DrivingAwardAffectBasic ScienceBioinformaticsBiopsyBirthBody WeightCareer DevelopmentCell CycleCell GrowthCell InjuryCell PhysiologyCells
Grant awards (5)
Ataxia Telangiectasia Mutated (ATM)-mediated hepatic DNA damage in pediatric nonalcoholic fatty liver disease$167,184
K08 · FY2025 · DK · contact PI
Ataxia Telangiectasia Mutated (ATM)-mediated hepatic DNA damage in pediatric nonalcoholic fatty liver disease$167,184
K08 · FY2024 · DK · contact PI
Ataxia Telangiectasia Mutated (ATM)-mediated hepatic DNA damage in pediatric nonalcoholic fatty liver disease$167,184
K08 · FY2023 · DK · contact PI
Ataxia Telangiectasia Mutated (ATM)-mediated hepatic DNA damage in pediatric nonalcoholic fatty liver disease$167,184
K08 · FY2022 · DK · contact PI
Ataxia Telangiectasia Mutated (ATM)-mediated hepatic DNA damage in pediatric nonalcoholic fatty liver disease$168,684
K08 · FY2021 · DK · contact PI